Loading...
Loading...
Dataset URI:
10.6084/m9.figshare.9927962.v1ABSTRACT: Ryegrass is an important weed in wheat cultivations due to the evolution of resistance to different mechanisms of action. This study aimed to compare the phenological development, fitness cost, and competitive ability between ryegrass biotypes susceptible and with multiple resistance to 5-enolpyruvylshikimate-3-phosphate synthase (EPSPs) and acetolactate synthase (ALS) inhibiting herbicides. Fitness cost and phenological development were evaluated from biotypes grown in pots, and morphological growth variables were determined up to 140 days after emergence. Phenological development was evaluated with a fitness cost. Competitive ability was determined in a replacement-series experiment with proportions of resistant and susceptible ryegrass. The tested proportions were 100:0 (pure resistant ryegrass stand), 75:25, 50:50, 25:75, and 0:100% (pure susceptible ryegrass stand), where the number of tillers, height, leaf area, and shoot dry matter were evaluated at 50 days after emergence. The longer tillering period of resistant ryegrass was the main factor involved in the difference in phenological development between biotypes. The resistant biotype was superior to the susceptible regarding height, shoot dry matter, and absolute growth rate, while the susceptible biotype had a higher number of tillers and leaf area ratio. Thus, the resistant biotype had no fitness cost. For competitive ability, no difference was observed between biotypes in the different tested proportions when they occupied the same ecological niche.
Keyword(s):
ALS; competition; EPSPs; Lolium multiflorum; Plant Biology.
MeSH Term(s):
Grants and Funding:
No Grants or Funding Data Available
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)